Celeste Anthony C.

CIK 00014157801 companyBETHESDA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001415780

Recent Transactions

31 trades

Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$6.80/sh+16,666→ 16,666 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-11−4,500→ 66,900 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-11−20,000→ 26,900 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-11−16,666→ 10,234 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$17.34/sh−4,500→ 0 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$17.34/sh−20,000→ 0 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-11−20,000→ 46,900 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2015-03-11−4,800→ 71,400 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$4.41/sh+4,800→ 4,800 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$8.62/sh+20,000→ 20,000 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$17.34/sh−20,000→ 0 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$17.34/sh−16,666→ 0 total
Sale
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$17.34/sh−4,800→ 0 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$4.41/sh+4,500→ 4,500 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2015-03-11$7.71/sh+20,000→ 20,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-14$5.10/sh+30,000→ 35,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-02-14−30,000→ 90,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-14$4.41/sh+13,800→ 68,800 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2014-02-14$3.56/sh+20,000→ 55,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-02-14−20,000→ 70,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-02-14−9,000→ 61,000 total
Exercise/Conversion
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (right to buy)
2014-02-14−4,800→ 56,200 total
Award
Sucampo Pharmaceuticals, Inc.
Director Stock Option (Right to Buy)
2013-05-22+20,000→ 120,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2012-05-25+20,000→ 20,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2011-05-02+12,000→ 12,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2011-05-02+18,000→ 18,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2010-05-20+20,000→ 20,000 total
Award
Sucampo Pharmaceuticals, Inc.
Employee Stock Option (Right to buy)
2009-10-07+30,000→ 30,000 total
Purchase
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2009-09-03$5.00/sh+1,100→ 5,000 total
Purchase
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2009-09-02$5.00/sh+1,400→ 1,400 total
Purchase
Sucampo Pharmaceuticals, Inc.
Class A Common Stock
2009-09-02$5.03/sh+2,500→ 3,900 total

Companies

Sucampo Pharmaceuticals, Inc.
Director

Recent Filings

Address

4520 EAST WEST HWY SUITE 300

BETHESDA, MD, 20814

View on SEC.gov